Ado-trastuzumab emtansine Intravenous and Von Willebrand factor recombinant
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Von Willebrand factor recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Von willebrand factor recombinant Intravenous
- Ado-trastuzumab emtansine Intravenous-Vonvendi
- Ado-trastuzumab emtansine Intravenous-Vopac
- Ado-trastuzumab emtansine Intravenous-Vopac MDS
- Ado-trastuzumab emtansine Intravenous-Vorapaxar
- Ado-trastuzumab emtansine Intravenous-Vorapaxar Sulfate
- Von Willebrand factor recombinant-Adox Pak 2/100
- Von Willebrand factor recombinant-Adoxa
- Von Willebrand factor recombinant-Adoxa CK
- Von Willebrand factor recombinant-Adoxa Pak
- Von Willebrand factor recombinant-Adoxa Pak 1/100
- Von Willebrand factor recombinant-Adoxa Pak 1/150